Recent Quotes (30 days)

You have no recent quotes
chg | %

Takeda Pharmaceutical Co Ltd news

   Watch this stock
Showing stories 1 - 10 of about 115   

Articles published

4502 4,548.00 +35.00 (0.78%)
price chart
Takeda Pharmaceutical Co Ltd sets bidding deadline for chemical firm stake ...
Takeda Pharmaceutical Co Ltd will accept initial bids for its 70 percent stake in a chemicals company through Aug. 16, with potential suitors including CVC Capital Partners Ltd and Carlyle Group Ltd, sources told Reuters.
BRIEF-Takeda Pharmaceutical Co Ltd receives positive CHMP opinion for ADCETRIS
May 27 Takeda Pharmaceutical Co Ltd : * Takeda receives positive CHMP opinion for ADCETRIS as consolidation treatment in post-transplant hodgkin lymphoma Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1 646 223 8780) ...
Tri-Institutional Therapeutics Discovery Institute, Inc. Expands Partnership ...
Under this expansion, Tri-I TDI will extend its current relationship with its industry partner, Takeda Pharmaceutical Company, Ltd. (TSE:4502) from the realm of small molecule discovery into the new research area of antibody drug discovery. All three ...
Prosetta Biosciences, Inc. And Takeda Pharmaceutical Company Limited, Enter ...
SAN FRANCISCO, May 2, 2016 /PRNewswire/ -- Prosetta Biosciences, Inc. (the "Company," or "Prosetta"), today announced that it has entered into a Feasibility and First Right of Negotiation Agreement (the "Agreement") with Takeda Pharmaceutical ...
Takeda Pharmaceutical Co. Ltd.
A vaccine for the world's most common cause of acute gastroenteritis and the USA's most common cause of foodborne illness is now in human clinical trials.
Takeda Pharmaceuticals starts clinical trial of norovirus vaccine  Digital Journal
Press Release from Business Wire : Takeda Pharmaceutical Company Limited
The Global Alliance for TB Drug Development (Headquarters: New York, USA, "TB Alliance") and Takeda Pharmaceutical Company Limited (Headquarters: Osaka, Japan; "Takeda") announced that they have entered into an agreement that further explores ...
Progress MN: Takeda Pharmaceutical Co. Limited
Sometimes the right property comes along at the right time. That was the case for the Minnesota division of Takeda, the Japan-based pharmaceutical giant, when it found a 215,000-square-foot building in Brooklyn Park that had previously been occupied by ...
Takeda and Nanotherapeutics Announce Agreement to Expand Takeda's ...
ALACHUA, Fla. & OSAKA, Japan--(BUSINESS WIRE)--Takeda Pharmaceutical Company Limited (Takeda) (TOKYO: 4502) and Nanotherapeutics, Inc., announced an agreement providing Takeda with expanded commercialization and technology access ...
Takeda Appoints New Chief Financial Officer, James Kehoe
OSAKA, Japan--(BUSINESS WIRE)--Takeda Pharmaceutical Company Limited (“Takeda”) (TOKYO:4502) today announced the appointment of James Kehoe as Takeda's new Chief Financial Officer and Corporate Officer, effective on June 15, 2016.
BRIEF-Takeda Pharmaceutical, Altos Therapeutics to develop Altos's ATC-1906
July 1 Takeda Pharmaceutical Co Ltd. * Co, Altos Therapeutics have entered into agreement to further development of Altos's proprietary compound ATC-1906.